Intraoperative labeling of sentinel lymph nodes with a combination of vital dye and radionuclide tracer - Results in sentinel lymph node-positive patients;Intraoperative markierung von sentinel-lymphknoten bei kombinierter anwendung von vitalfärbung und radiotracer - Ergebnisse bei sentinel-lymphknoten-positiven patienten

JDDG - Journal of the German Society of Dermatology

Volumn 4, Issue 3, 2006, Pages 229-234

  Pfutzner W ^a   Kunte, Christian ^a   Weiss, Mayo ^b   Flaig, Michael I ^a   Konz, Birger ^a  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^b UNIVERSITY OF MUNICH   (Germany)

Author keywords

Diagnostics; Melanoma; Metastasis; Sentinel lymph node

Indexed keywords

RADIOISOTOPE;

ARTICLE; CANCER PATIENT; CELL LABELING; CONTROLLED STUDY; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INTRAOPERATIVE PERIOD; ISOTOPE LABELING; MELANOMA; MICROMETASTASIS; RETROSPECTIVE STUDY; SENTINEL LYMPH NODE BIOPSY; TISSUE SECTION; TUMOR VOLUME; VITAL STAIN;

EID: 33645562080     PISSN: 16100379     EISSN: 16100387     Source Type: Journal    
DOI: 10.1111/j.1610-0387.2006.05926.x     Document Type: Article

References (32)

1. Morton DL, Bostick PJ. Will the true sentinel node please stand? Ann Surg Oncol 1999; 6: 12-14.
2. Gershenwald JE, Thompson W, Mansfield PF, Lee JE, Colome MJ. Multi-institutional melanoma lymphatic mapping experience: The prognostic value of sentinel lymph node status in 612 stage I or II melanoma patients. J Clin Oncol 1999; 17: 976-983.
3. Muller MGS, van Leeuwen PAM, de Lange-de Klerk ESM, van Diest PJ, Pijpers R, Ferwerda CC, Vuylsteke RJCLM, Meijer S. The sentinel lymph node status is an important factor for predicting clinical outcome in patients with stage I or II cutaneous melanoma. Cancer 2001; 91: 2401-2408.
4. Möhrle M, Schippert W, Rassner G, Garbe C, Breuninger H. Micrometastasis of a sentinel lymph node in cutaneous melanoma is a significant prognostic factor for disease-free survival, distant-metastasis-free survival, and overall survival. Dermatol Surg 2004; 30: 1319-1328.
5. Leong SPL. The role of sentinel lymph nodes in malignant melanoma. Surg Clin North Am 2000; 80: 1741-1757.
6. Konz B, Weiss M, Sander C, Volkenandt M, Hahn K, Plewig G. "Sentinel-Lymph-Node" Exstirpation. Münch Med Wochenschr 1998; 140: 320-325.
7. Konz B, Wörle B. Resektionsabstand und Vorposten-Lymphknoten: Aktuelle Empfehlungen zur operativen Therapie. In: Plewig G, Degitz K: Fortschritte der praktischen Dermatologie und Venerologie. Berlin, Heidelberg: Springer Verlag, 2001: 281-289.
8. Wagner JD, Sondak VK. The sentinel lymph node: More than just another blue lymph node. Cancer 2003; 97: 1821-1823.
9. Arens A, Osinga J, Schwipper V, Schober O, Tilkorn H, Liebau J. Sentinel-Lymphknoten-Dissektion beim malignen Melanom. Ein diagnostischer und therapeutischer Standard. Chirurg 2003; 74: 665-670.
10. Norman J, Cruse C, Espinosa C, Cox C, Reintgen D. Redefinition of cutaneous lymphatic drainage with the use of lymophoscintigraphy for malignant melanoma. Am J Surg 1991; 162: 432-37.
11. Morton DL, Wen DR, Wong JH, Economou JS, Cagle LA, Storm FK, Foshag LJ, Cochran AJ. Technical details of intraoperative lymphatic mapping for early stage melanoma. Arch Surg 1992; 127: 392-399.
12. Wong JH, Cagle LA, Morton DL. Lymphatic drainage of skin to a sentinel lymph node in a feline model. Ann Surg 1991; 214: 637-641.
13. Krag DN, Meijer S, Weaver D. Minimal-access surgery for staging of melanoma. Arch Surg 1995; 130: 654-658.
14. Alex JC, Krad DN. Gamma-probe-guided localization of lymph nodes. Surg Oncol 1993; 2: 137-143.
15. Nathanson SD. Will the true sentinel node please stand? [letter] Ann Surg Oncol 1999; 6: 514-516.
16. Krag D, Weaver D, Ashikaga T. The sentinel node in breast cancer - a multicenter validation study. New Engl J Med 1999; 339: 941-946.
17. Nieweg OE, Tanis PJ, Kroon BBR. The definition of a sentinel node. Ann Surg Oncol 2001; 8: 538-541.
18. Perrott RE, Glass LF, Reintgen DS, Fenske NA. Reassessing the role of lymphatic mapping and sentinel lymphadenectomy in the management of cutaneous malignant melanoma. J Am Acad Dermatol 2003; 49: 567-588.
19. Kapteijn BAE, Nieweg OE, Liem IH, Mooi WJ, Balm AJM, Muller SH, Peterse JL, Valdes Olmos R, Hoefnagel CA, Kroon BBR. Localizing the sentinel node in cutaneous melanoma: Gamma probe detection versus blue dye. Ann Surg Oncol 1997; 4: 156-160.
20. McMasters KM, Reintgen DS, Ross MI, Wong SL, Gershenwald JE, Krag DN, Noyes RD, Viar V, Cerrito PB, Edwards MJ. Sentinel lymph node biopsy for melanoma: How many radioactive nodes should be removed? Ann Surg Oncol 2001; 8: 192-197.
21. Albertini JJ, Cruse CW, Rapaport D, Wells K, Ross M, DeConti R, Berman CG, Jared K, Messina J, Lyman G, Glass F, Fenske N, Reintgen DS. Intraoperative radiolymphoscintigraphy improves sentinel lymph node identification for patients with melanoma. Ann Surg 1996; 223: 217-224.
22. Carlson GW, Murray DR, Thourani V, Hestley A, Cohen C. The definition of the sentinel lymph node in melanoma based on radioactive counts. Ann Surg Oncol 2002; 9: 929-933.
23. Bostick P, Essner R, Glass E, Kelley M, Sarantou T, Foshag LJ. Comparison of blue dye and probe-assisted intraoperative lymphatic mapping in melanoma to identify sentinel nodes in 100 lymphatic basins. Arch Surg 1999; 134: 43-49.
24. Tafra L, Chua AN, Ng PC, Aycock D, Swanson M, Lannin D. Filtered versus unfiltered technetium sulfur colloid in lymphatic mapping: A significant variable in a pig model. Ann Surg Oncol 1999; 6: 83-87.
25. Nathanson SD, Anaya P, Karvelis KC, Eck L, Havstad S. Sentinel lymph node uptake of 2 different technetium-labeled radiocolloids. Ann Surg Oncol 1997; 4: 104-110.
26. Steinke R, Schuldt S, Kühne KH, Otto HJ, Gollnick A. Die Lymphstromszintigraphie beim malignen Melanom - Stellenwert für Therapie und Prognose. Nuklearmedizin 1997; 37: A96.
27. Thompson JF, Uren RF, Shaw HM, Carthy WH, Quihn MJ. Location of sentinel lymph nodes in patients with cutaneous melanoma: New insights into lymphatic anatomy. J Am Coll Surg 1999; 189: 195-206.
28. Leong SP, Achtem TA, Habib FA, Steinmetz I, Morita ET, Allen RE, Kashani-Sabet M, Sagebiel RW. Discordancy between clinical predictions vs lymphoscintigraphic and intraoperative mapping of sentinel lymph node drainage of primary melanoma. Arch Dermatol 1999; 135: 1472-1476.
29. Gennari R, Bartolomei M, Testori A, Zurrida S, Stoldt HS, Audisio RA, Geraghty JG, Paganelli C, Veronesi U. Sentinel node localization in primary melanoma: Preoperative dynamic lymphoscintigraphy, intraoperative gamma probe, and vital dye guidance. Surgery 1999; 126: 19-25.
30. Leong SP, Steinmetz I, Habib FA, McMillan A, Gans JZ, Allen RE, Morita ET, El-Kadi M, Epstein HD, Kashani-Sabet M, Sagebiel RW. Optimal selective lymph node dissection in primary malignant melanoma. Arch Surg 1997; 132: 666-672.
31. Jansen L, Nieweg OE, Kapteijn BAE, Valdes Olmos RA, Muller SH, Hoefnagel CA, Kroon BBR. Reliability of lymphoscintigraphy in indicating the number of sentinel nodes in melanoma patients. Ann Surg Oncol 2000; 7: 624-630.
32. Villa G, Agnese G, Bianchi P, Buffoni F, Costa R, Carli F, Peressini A, Solari N, Cafiero F, Mariani G. Mapping the sentinel lymph node in malignant melanoma by blue dye, lymphoscintigraphy and intraoperative gamma probe. Tumori 2000; 86: 343-345.